1,981
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Antifungal activity of osthol in vitro and enhancement in vivo through Eudragit S100 nanocarriers

, , , , , , , , , & show all
Pages 555-562 | Received 07 Sep 2016, Accepted 06 Jul 2017, Published online: 27 Feb 2018

References

  • Castanheira M, Messer SA, Jones RN, Farrell DJ, Pfaller MA. Activity of echinocandins and triazoles against a contemporary (2012) worldwide collection of yeast and moulds collected from invasive infections. Int J Antimicrob Agents, 2014;44:320-6; http://doi.org/10.1016/j.ijantimicag.2014.06.007; PMID:25129315
  • Liao Y, Chen M, Hartmann T, Yang RY, Liao WQ. Epidemiology of opportunistic invasive fungal infections in China: Review of literature. Chin Med J, 2013;126:361-8; PMID:23324290
  • Kohli A, Smriti Mukhopadhyay K, Rattan A, Prasad R. In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry. Antimicrob Agents Chemother, 2002;46:1046-52; http://doi.org/10.1128/AAC.46.4.1046-1052.2002; PMID:11897588
  • Edwards JE Jr., Bodey GP, Bowden RA, Buchner T, de Pauw BE, Filler SG, Ghannoum MA, Glauser M, Herbrecht R, Kauffman CA, et al. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis, 1997;25:43-59; http://doi.org/10.1086/514504; PMID:9243032
  • Kelly SL, Arnoldi A, Kelly DE. Molecular genetic analysis of azole antifungal mode of action. Biochem Soc Trans, 1993;21:1034-8; http://doi.org/10.1042/bst0211034; PMID:8131893
  • White TC, Holleman S, Dy F, Mirels LF, Stevens DA. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother, 2002;46:1704-13; http://doi.org/10.1128/AAC.46.6.1704-1713.2002; PMID:12019079
  • White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev, 1998;11:382-402; PMID:9564569
  • Ng TT, Denning DW. Fluconazole resistance in Candida in patients with AIDS–a therapeutic approach. J Infect, 1993;26:117-25; http://doi.org/10.1016/0163-4453(93)92707-4; PMID:8473758
  • You L, Feng S, An R, Wang X. Osthole: A promising lead compound for drug discovery from a traditional Chinese medicine (TCM). Nat Prod Commun, 2009;4:297-302; PMID:19370943
  • Matsuda H, Tomohiro N, Ido Y, Kubo M. Anti-allergic effects of cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, osthol. Bio Pharm Bull, 2002;25:809-12; http://doi.org/10.1248/bpb.25.809; PMID:12081154
  • Chao X, Zhou J, Chen T, Liu W, Dong W, Qu Y, Jiang X, Ji X, Zhen H, Fei Z. Neuroprotective effect of osthole against acute ischemic stroke on middle cerebral ischemia occlusion in rats. Brain Res, 2010;1363:206-11; http://doi.org/10.1016/j.brainres.2010.09.052; PMID:20869955
  • Liu WB, Zhou J, Qu Y, Li X, Lu CT, Xie KL, Sun XL, Fei Z. Neuroprotective effect of osthole on MPP+-induced cytotoxicity in PC12 cells via inhibition of mitochondrial dysfunction and ROS production. Neurochem Int, 2010;57:206-15; http://doi.org/10.1016/j.neuint.2010.05.011; PMID:20510317
  • Kawaii S, Tomono Y, Ogawa K, Sugiura M, Yano M, Yoshizawa Y, Ito C, Furukawa H. Antiproliferative effect of isopentenylated coumarins on several cancer cell lines. Anticancer Res, 2001;21:1905-11; PMID:11497276
  • Xu X, Zhang Y, Qu D, Jiang T, Li S. Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway. J Exp Clin Cancer Res, 2011;30:33; http://doi.org/10.1186/1756-9966-30-33; PMID:21447176
  • Wang L, Peng Y, Shi K, Wang H, Lu J, Li Y, Ma C. Osthole inhibits proliferation of human breast cancer cells by inducing cell cycle arrest and apoptosis. J Biomed Res, 2015;29:132-8; http://doi.org/10.7555/JBR.27.20120115; PMID:25859268
  • Zhou ZW, Liu PX. [Progress in study of chemical constituents and anti-tumor activities of Cnidium monnieri]. Zhongguo Zhong Yao Za Zhi, 2005;30:1309-13; PMID:16323535
  • Li L, Zhuang FE, Yang L, Zhang CL, Zhao GS, Zhao DK. Effects of osthole on isolated guinea pig heart atria. Zhongguo Yao Li Xue Bao, 1995;16:251-4; PMID:7660822
  • Chen YF, Tsai HY, Wu TS. Anti-inflammatory and analgesic activities from roots of Angelica pubescens. Planta Medica, 1995;61:2-8; http://doi.org/10.1055/s-2006-957987; PMID:7700984
  • Zimecki M, Artym J, Cisowski W, Mazol I, Wlodarczyk M, Glensk M. Immunomodulatory and anti-inflammatory activity of selected osthole derivatives. Z Naturforsch C, 2009;64:361-8; http://doi.org/10.1515/znc-2009-5-610; PMID:19678539
  • Nakamura T, Kodama N, Arai Y, Kumamoto T, Higuchi Y, Chaichantipyuth C, Ishikawa T, Ueno K, Yano S. Inhibitory effect of oxycoumarins isolated from the Thai medicinal plant Clausena guillauminii on the inflammation mediators, iNOS, TNF-alpha, and COX-2 expression in mouse macrophage RAW 264.7. J Nat Med, 2009;63:21-7; http://doi.org/10.1007/s11418-008-0277-5; PMID:18636311
  • Liao PC, Chien SC, Ho CL, Wang EI, Lee SC, Kuo YH, Jeyashoke N, Chen J, Dong WC, Chao LK, et al. Osthole regulates inflammatory mediator expression through modulating NF-kappaB, mitogen-activated protein kinases, protein kinase C, and reactive oxygen species. J Agric Food Chem, 2010;58:10445-51; http://doi.org/10.1021/jf102812t; PMID:20839800
  • Rosselli S, Maggio A, Bellone G, Formisano C, Basile A, Cicala C, Alfieri A, Mascolo N, Bruno M. Antibacterial and anticoagulant activities of coumarins isolated from the flowers of Magydaris tomentosa. Planta Medica, 2007;73:116-20; http://doi.org/10.1055/s-2006-951772; PMID:17128388
  • Wang CM, Guan W, Fang S, Chen H, Li YQ, Cai C, Fan YJ, Shi ZQ. Antifungal activity of the osthol derivative JS-B against Phytophthora capsici. J Asian Nat Prod Res, 2010;12:672-9; http://doi.org/10.1080/10286020.2010.495331; PMID:20706903
  • Figueroa M, Rivero-Cruz I, Rivero-Cruz B, Bye R, Navarrete A, Mata R. Constituents, biological activities and quality control parameters of the crude extract and essential oil from Arracacia tolucensis var. multifida. J Ethnopharmacol, 2007;113:125-31; http://doi.org/10.1016/j.jep.2007.05.015; PMID:17582715
  • Wang CM, Zhou W, Li CX, Chen H, Shi ZQ, Fan YJ. Efficacy of osthol, a potent coumarin compound, in controlling powdery mildew caused by Sphaerotheca fuliginea. J Asian Nat Prod Res, 2009;11:783-91; http://doi.org/10.1080/10286020903158964; PMID:20183325
  • Zhou J, Wang SW, Sun XL. Determination of osthole in rat plasma by high-performance liquid chromatograph using cloud-point extraction. Anal Chim Acta, 2008;608:158-64; http://doi.org/10.1016/j.aca.2007.12.029; PMID:18215647
  • Li Y, Meng F, Xiong Z, Liu H, Li F. HPLC determination and pharmacokinetics of osthole in rat plasma after oral administration of Fructus Cnidii extract. J Chromatogr Sci, 2005;43:426-9; http://doi.org/10.1093/chromsci/43.8.426; PMID:16212784
  • Lv X, Wang CY, Hou J, Zhang BJ, Deng S, Tian Y, Huang SS, Zhang HL, Shu XH, Zhen YH, et al. Isolation and identification of metabolites of osthole in rats. Xenobiotica, 2012;42:1120-7; http://doi.org/10.3109/00498254.2012.689887; PMID:22630788
  • An F, Wang SH, Zhang DS, Zhang L, Mu JX. [Pharmacokinetics of osthole in rabbits]. Yao Xue Xue Bao, 2003;38:571-3; PMID:14628444
  • Zhang L, Yan R, Su R, Yang C, Liu S, Yu X, Chang X, Zhang S, Liu C, Xu M, et al. Bioavailability enhancement of osthole after oral administration of Bushen Yizhi prescription extract to rats followed by Cnidium monnieri (L.) Cusson fruits extract in comparison to pure osthole at different doses. J Ethnopharmacol, 2014;152:266-71; http://doi.org/10.1016/j.jep.2013.09.045; PMID:24140583
  • Aberturas MR, Molpeceres J, Guzman M, Garcia F. Development of a new cyclosporine formulation based on poly(caprolactone) microspheres. J Microencapsul, 2002;19:61-72; http://doi.org/10.1080/02652040110055270; PMID:11811760
  • Ritschel WA. Microemulsion technology in the reformulation of cyclosporine: The reason behind the pharmacokinetic properties of Neoral. Clin Transplant, 1996;10:364-73; PMID:8884110
  • Zhang Q, Yie G, Li Y, Yang Q, Nagai T. Studies on the cyclosporin A loaded stearic acid nanoparticles. Int J Pharm, 2000;200:153-9; http://doi.org/10.1016/S0378-5173(00)00361-6; PMID:10867245
  • Sonaje K, Italia JL, Sharma G, Bhardwaj V, Tikoo K, Kumar MN. Development of biodegradable nanoparticles for oral delivery of ellagic acid and evaluation of their antioxidant efficacy against cyclosporine A-induced nephrotoxicity in rats. Pharm Res, 2007;24:899-908; http://doi.org/10.1007/s11095-006-9207-y; PMID:17377747
  • Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: The state of the art. Crit Rev Ther Drug Carrier Syst, 2004;21:387-422; http://doi.org/10.1615/CritRevTherDrugCarrierSyst.v21.i5.20; PMID:15719481
  • Eerikainen H, Kauppinen EI. Preparation of polymeric nanoparticles containing corticosteroid by a novel aerosol flow reactor method. Int J Pharm, 2003;263:69-83; http://doi.org/10.1016/S0378-5173(03)00370-3; PMID:12954182
  • Shi Z, Shen S, Zhou W, Wang F, Fan Y. Fusarium graminearum growth inhibition due to glucose starvation caused by osthol. Int J Mol Sci, 2008;9:371-82; http://doi.org/10.3390/ijms9030371; PMID:19325755
  • Yuan Z, Xu H, Wang K, Zhao Z, Hu M. Determination of osthol and its metabolites in a phase I reaction system and the Caco-2 cell model by HPLC-UV and LC-MS/MS. J Pharm Biomed Anal, 2009;49:1226-32; http://doi.org/10.1016/j.jpba.2008.12.001; PMID:19304430
  • Moody DE, Liu F, Fang WB. Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism. J Anal Toxicol, 2015;39:374-86; http://doi.org/10.1093/jat/bkv030; PMID:25868557
  • Fu Z, Lu H, Zhu Z, Yan L, Jiang Y, Cao Y. Combination of baicalein and Amphotericin B accelerates Candida albicans apoptosis. Biol Pharm Bull, 2011;34:214-8; http://doi.org/10.1248/bpb.34.214; PMID:21415530
  • Huang S, Cao YY, Dai BD, Sun XR, Zhu ZY, Cao YB, Wang Y, Gao PH, Jiang YY. In vitro synergism of fluconazole and baicalein against clinical isolates of Candida albicans resistant to fluconazole. Biol Pharm Bull, 2008;31:2234-6; http://doi.org/10.1248/bpb.31.2234; PMID:19043205
  • Sun LM, Cheng AX, Wu XZ, Zhang HJ, Lou HX. Synergistic mechanisms of retigeric acid B and azoles against Candida albicans. J Appl Microbiol, 2010;108:341-8; http://doi.org/10.1111/j.1365-2672.2009.04429.x; PMID:20002912
  • Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother, 2003;52:1; http://doi.org/10.1093/jac/dkg301; PMID:12805255
  • Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF, Jiang YY. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob Agents Chemother, 2006;50:1096-9; http://doi.org/10.1128/AAC.50.3.1096-1099.2006; PMID:16495278
  • Richardson K, Brammer KW, Marriott MS, Troke PF. Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrob Agents Chemother, 1985;27:832-5; http://doi.org/10.1128/AAC.27.5.832; PMID:2990328
  • Clark JM, Whitney RR, Olsen SJ, George RJ, Swerdel MR, Kunselman L, Bonner DP. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother, 1991;35:615-21; http://doi.org/10.1128/AAC.35.4.615; PMID:2069367